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Some Perspectives on Monoamine-Opioid 
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Central Nervous System’ 
KHACHATURIAN, H, AND S. J. WATSON. Someperspecfives on monoamine-opioid peptide interaction in rat central 
nervous system. BRAIN RES. BULL.9(1-6) 441-462, 1982.-Light microscopic imm~ocy~ch~m~st~ was employed to 
investigate possible sites of interaction between the endogenous opioid peptides and monoamines in the rat central nervous 
system. The opioid and related peptides examined included beta-endorphin @-END), alpha-MSH (a-MSH) and bucine- 
enkephahn (Leu-ENK). The monoamines were examined using antisera generated against tyrosine hydroxylase, 
dopamine-P-hydroxylase as well as serotonin. Due to the long-tract nature of the central monoamine prajections as well as 
P-END/a-MSH fiber systems, serial section analyses were performed utilizing parasagittal brain sections. Many areas rich 
in both the monoamines as well as opioid peptides were investigated. These included several thahunic and hypothalamic 
nuclei, several limbic structures, mesencephabc periaqueductal gray, brain stem noradrenergic cell groups and their rostral 
projections, the dopaminergic nigrostriati system, and the serotonergic raphe nuclei and their projections. The results 
suggest a more intimate linkage between the monoamines and the opioid peptides than previous& reahzed. Some of the 
intricacies of monoamine-opioid peptide interaction, in particular those pertaining to their possible roie in pain and 
analgesia, catalepsy, and neuroendocrine effects are also discussed. 
Opioid peptides Monoamines Hypathalamus 
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EVER since the discovery of endogenous opioid peptides 
and their subsequent localization in specific central nervous 
system loci, it has become increasingly apparent that there 
exists a potential for an intimate interaction between these 
peptides and the mono~inergic systems. In fact, many in- 
vestigators have noted the possibility of such an interaction 
while studying the distributional patterns of the opioid pep- 
tides (cf. [ ISI]), In this chapter, we shah present data from 
our recent immunocytochemical studies suggesting a much 
more intimate linkage between the opioid peptides and 
monoamines than previously realized. Additionally, we will 
analyze some of the more sahent features of mo~oamine- 
opioid peptide interaction in the rat centrat nervous system. 
Heavier emphasis will be placed upon the anatomical aspects 
of these interactions, along with the discussion of possible 
physiological implications where such is applicable. This ar- 
ticle then is not an exhaustive review of the literature, rather 
a specialized, and we hope useful treatise of this subject. For 
those who have fur&r interests in the topic, there will be 
references made to some of the more thorough reviews of the 
literature. 
ENDOGENOUS OPIOID SYSTEMS 
It is now clear that there exists within the central nervous 
system three distinct opioid peptidergic systems, namely 
those containing methionine- and Ieucine-enkephalin (met- 
and leu-ENK), beta-endorphin (P-END), and dynorphin 
(DYN) (and possibly cy- and @-neo-endorphin). The opioid 
peptides demonstrate a high affinity for opiate receptors, and 
can induce narcotic agonist effects much like those produced 
by morphine administration. These effects have been 
demonstrated for met- and leu-ENK [23,55,56,69, 106, 1361 
for P-END [lQ, 22, 74, 75, 83, 84, 138, 139, 1541, and for 
DYN [41]. Furthermore, immunocytochemical studies have 
revealed a separate and distinct distributional pattern for 
each of the opioid peptides. 
Ergkephalins 
The enkephalins were discovered in the mammalian brain 
by Hughes et al. [56], and were shown to exist in entirely 
separate neuronal systems from that containing P-END and 
its related peptides [16,1491. Met- and leu-ENK containing 
perikarya and f%ers have a wide distribution throughout the 
neuraxis, and can be found in certain fimbic structures, neo- 
striatum, hypothalamus, periventricuhu and periaqueductal 
gray areas, locus coeruleus, as well as many lower brain 
stem structures and the spinal cord [32,48,X), 60, 125, 131, 
141, 142, 147, 1551. Although these two peptides appear to 
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TABLE 1 
ANTIBODIES USED IN THIS STUDY 
Antibody Source Specificity Key Cross Reactivities 
P-END Watson and Akil 
(affinity) 
P-END 
(43 Watson and Akil 
(Y-MSH Watson and Akil 
leu-ENK Watson and Akil 
Tyrosine hydroxylase T. Joh 
Dopamine+hydroxylase Watson, Akil, and 
Ciaranello 
Serotonin Watson and Akil 
C-terminus 64% XR-/3,-LPH 
LPH,, -9, 100% XR-P,-LPH 
COOH terminus CO. 1% XR-ACTH 
COOH terminus ~6% XR-Met-enkephalin 
Not DBH or PNMT 
Single IEP band and 
single PAGE 
Not Melatonin, Seems to see SHT only 
Tryptophan or 
5-OHTRP, L-DOPA, etc. 
have similar anatomical 
have presented evidence 
met- and leu-ENK. 
/3-Endorphin 
distributions, Larsson et al. [68] 
for separate neuronal systems for 
On the other hand, P-END [19,43,74], appears to exist in 
the anterior pituitary corticotrophs and intermediate lobe 
melanotrophs along with adrenocorticotrophic (ACTH) and 
melanocyte stimulating (a-MSH) hormones, respectively 
[15,108]. It has also been shown to exist in the brain in 
neuronal perikarya located in the arcuate and peri-arcuate 
regions of the hypothalamus. Fibers from this single system 
which also stores ACTH and a-MSH, project to hypothala- 
mus, several limbic areas, periventricular thalamus, 
periaqueductal gray, the locus coeruleus, and medullary re- 
ticular formation [S, 6, 14, 16, 17, 148, 149, 150, 1621. Re- 
cently, other P-END containing neuronal perikarya have 
been localized in the brain stem of colchicine pre-treated 
rats, in the vicinity of the A2 noradrenergic cell group [ 1281 
and within nucleus reticularis gigantocellularis and motor 
trigeminal nucleus [36]. However, it remains to be seen 
whether or not these cells contain “true” P-END. 
Dynorphin 
Lastly, DYN, discovered by Goldstein et al. [41] appears 
to contain the leu-ENK molecule as its N-terminus, just as 
P-END contains met-ENK at its N-terminus. However, the 
COOH-terminus of DYN is unique to that peptide only. This 
peptide has been found to exist in the same hypothalamic 
magnocellular neurons that produce vasopressin in both the 
supraoptic and paraventricular nuclei. It has also been lo- 
calized to medullary and spinal cord neurons [ 152.1531. 
MONOAMINERGIC SYSTEMS 
Norepinephrine (NE) 
Noradrenergic systems arise from several brain stem loci 
and have extensive and widespread projections throughout 
the neuraxis [26,77, 1431. The nucleus locus coeruleus is the 
largest NE producing nucleus and is the primary source of 
central noradrenergic innervation, giving rise to fibers that 
course through the dorsal NE bundle in the midbrain 
periaqueductal gray to higher structures [7, 77, 811. Other 
NE-producing cell groups collectively known as the lateral 
tegmental noradrenergic system, give rise to both descend- 
ing and ascending (ventral NE-bundle) projections. NE ter- 
minals can be found in the spinal cord, brain stem, thalamus 
and hypothalamus, as well as many limbic and other telence- 
phalic structures. 
Dopamine (DA) 
The dopaminergic cell groups of the mesencephalon [26], 
the most prominent of which is located in the substantia 
nigra give rise to ascending projections to the neostriatum 
(Caudate-putamen) via the nigrostriatal pathway, as well as 
other limbic and forebrain structures via the mesolimbic and 
mesocortical DA pathways which project to the nucleus ac- 
cumbens, lateral septum and several cortical areas 177, 79, 
80, 1431. Additionally the tuberoinfundibular DA neurons in 
the arcuate-periventricular region and the incer- 
tohypothalamic DA neurons in the zona incerta seem to 
exert their action upon the endocrine hypothalamus [ 13,491. 
Serotonin (5HT) 
5HT neuronal systems originate from the nuclei of the 
raphe which are midline structures in the regions of the mes- 
encephalon, pons, and medulla [26]. Two of the most 
prominent 5HT nuclei are the raphe dorsalis and raphe mag- 
nus. These and other raphe neurons give rise to several 
pathways which include: ventral and dorsal ascending as 
well as other descending pathways to the spinal cord [26, 27, 
39, 1431. Raphe dorsalis projections ascend periventricular- 
ly to innervate the locus coeruleus, mesencephalic 
periaqueductal gray as well as hypothalamus. Raphe magnus 
5HT neurons project to the spinal cord, brainstem, locus 
coeruleus, substantia nigra, thalamus. hypothalamus, 
striatum, habenula, septum, amygdala, hippocampus and 
neocortex. 
METHOD 
A total of 6 normal male Sprague-Dawley rats (Charles 
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FIG. 1. Schematic representation of monoaminergic nuclei and projections (solid lines) in a parasagittal view of the rat brain, modified from 
Pellegrino er al. [ 1071. The locations of noradrenrgic, dopaminergic, and serotonergic nuclei and pathways were approximated using the works 
of Dahlstriim and Fuxe [26], Fuxe [38], Ungerstedt [143], and Lindvall and Bjorklund [78]. No monoamine cell bodies are shown. Superim- 
posed upon the monoaminergic systems are the projections of P-END/a-MSH fibers (dashes) which originate from cell bodies in the 
hypothalamic arcuate nucleus. Also shown are /3-END/WMSH cell bodies in the intermediate and anterior lobes of the pituitary. Note the 
close association between the projections of these systems. The projections of the a-2 ((r-MSH) system to the cortex and hippocampus are not 
shown. The reader is cautioned that due to the wealth of data, this schematic drawing is necessarily oversimplified. Also, many monoamine 
nuclei were omitted. Abbreviations: Al, A2, (noradrenergic cell groups). AC (anterior commissure). ACB (nucleus accumbens). AL (anterior 
lobe of pituitary). ARN (arcuate nucleus). CC (corpus callosum). CPU (caudate-putamen). DCA (dorsal catecholamine bundle). HPC 
(hippocampus). IC (inferior colliculus). IL (intermediate lobe of pituitary). LC (locus coeruleus). ME (median eminence). MFB (medial 
forebrain bundle). NL (neural lobe of pituitary). NTS (nucleus tractus solitarius). OB (olfactory bulb). OT (optic tract). P (pons). PAG 
(periaqueductal gray). PV (periventricular thalamus). RD (raphe dorsalis). RM (raphe magnus). SC (superior colliculus). SN (substantia 
nigra). SPT (septum). V (ventricle). VCA (ventral catecholamine bundle). 
River) were used in this study. The immunocytochemical 
technique used here is described elsewhere [148,149]. 
Briefly, each animal is anesthetized by an intraperitoneal 
injection of sodium pentobarbital. The animal is then im- 
mersed in ice-water and the chest cavity is opened. The right 
atrium is cut open and the cardiovascular system is flushed 
with 50 ml cold saline administered through the left ventricle. 
The ventricles are cut away and a perfusion tube is inserted 
into the aorta and tied in place. The animal is perfused with 
4% buffered formaldehyde at 4°C for 30 minutes. The brain is 
then excised, blocked and placed in the perfusion mixture for 
one hour at 4°C. Next, the blocks are transferred into 15% 
sucrose in phosphate buffered saline (PBS) and stored over- 
night at 4°C. The following day, the blocks are immersed in 
Tissue Tek (O.C.T.) and are frozen by immersion into liquid 
nitrogen. For sectioning, the O.C.T. blocks are frozen onto 
brass cryostat chucks and sectioned at -20°C. In this study, 
the brains were sectioned at the sagittal plane. The sections 
are picked up onto gelatin-coated slides and are stored at 
-90°C until further processing. 
For immunocytochemistry, the sections are air-dried and 
placed in an incubator, set at 37°C. Primary rabbit antisera 
against particular antigens (see Table 1) are diluted with 0.3% 
T&on-PBS and applied to the sections and allowed to incu- 
bate for one hour. These are then incubated overnight at 4°C. 
The following day, the slides are washed in PBS and then 
incubated with goat anti-rabbit immunoglobulin (GAR-IgG) 
for 1 hour at 37°C and then overnight at 4°C. On the third 
day, the slides are once more washed in PBS and the sec- 
tions are incubated with peroxidase-antiperoxidase (PAP) 
complex for one hour at 37°C. Alternatively, some sections 
are incubated in successive steps with antiperoxidase 
antibody followed by peroxidase enzyme, each for 40 min- 
utes. The slides are washed in PBS and are placed in a PBS 
solution of 12.5% diaminobenzidine tetrahydrochloride 
(DAB) and 0.03% H,O, for 15 minutes. The sections are then 
washed, osmicated, washed, dehydrated and mounted in 
permount. See Table 1 for a list of antisera used and their 
characteristics. 
Analyses 
Since the monoaminergic neurons form long tract sys- 
tems, it was advantageous to evaluate possible areas of in- 
teraction between these neurotransmitters and opioid pep- 
tides C(3-END/o-MSH neurons also have long tract projec- 
tions) in brains that were cut in the sagittal plane. The thick- 
ness of the sections varied from animal to animal and was in 
the range of 10-20 pm. In each animal the right side of the 
brain was examined. Serial parasagittal sections were ob- 





FIG. 2. Lateral septum: In these panels the common distribution of tyrosine hydroxylase (TH), leu-ENK (LE), 5HT, and cu-MSH (also 
represents P-END) immunoreactive fibers are demonstrated in serial parasagittal sections (A through D) through the lateral septum (see Fig. 1 
for orientation). Note the fine 5HT innervation of the ependyma. V (third ventricle). Bar=50 pm. 
tamed and every 10th section was stained with a Nissl stain 
for orientation purposes. The subsequent sections were 
stained immunocytochemically with antisera against the fol- 
lowing substances (Table 1): P-END, a-MSH, leu-ENK, 
serotonin (5HT), tyrosine hydroxylase, and dopamine-/!I- 
hydroxylase. Observations and photographic analyses were 
made using a Leitz Orthoplan microscope equipped with an 
automatic camera system. 
RESULTS AND DISCUSSION 
Since data presented in this section are in the form of 
high-power photomicrographs through several regions of the 
brain in parasagittal sections, the reader is referred to Fig. 1 
for a brief introduction as well as for orientation in the sub- 
sequent figures. 
Norepinephrine-Opioid Peptide Inteructions 
The results of this study confirm and further extend the 
evidence for an extensive interaction between the norad- 
renergic and opioid peptide systems (references below). 
Many brain areas that contain opioid peptides are also rich in 
tyrosine hydroxylase and dopamine-P-hydroxylase im- 
munoreactivities (these enzymes are responsible for the syn- 
thesis of DA and NE). This is especially true in the case of 
@-END/a-MSH projections which appear to coincide with 
NE projections. Thus, /3-END/a-MSH fibers and terminals 
were noted in many brain loci rich in NE, such as anterior 
hypothalamic and preoptic areas (particularly the medial 
forebrain bundle), dorsomedial nucleus of the hypothalamus, 
septal nuclei (Fig. 2), nucleus accumbens, periventricular 
nucleus of thalamus (Fig. 3), periaqueductal gray (Fig. 4). 
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FIG. 3. Periventrkutar thalamus: Serial parasagittal sections (A through D) through the periventricular nucleus of the thalamus (see Fig. 1 for 
orientation) showing the proximity of tyrosine hydroxylase (TH), leu-ENK (LE), 5HT and wMSH (also represents P-END) immunoreac- 
tivities. Bar=50 pm. 
several raphe nuclei (Figs. 13, 14) as well as other norad- 
renergic cell groups including the locus coeruleus (Figs. 5, 
6). fnterestingiy, we have noted many P-END/cl-MSH im- 
munoreactive fibers in both the “dorsal and ventral norad- 
renergic bundles” (Fig. 7), giving the impression that these 
peptidergic fibers follow the classical monoamine pathways 
in a retrograde fashion. Additionally, (w-MSH (from a sepa- 
rate cu-MSH neuronal system which does not contain 
@-END; [144,145]) fibers were also detected in the cortex 
and hippocampus, reaching these sites via the monoamine- 
rich cingulum bundle. Furthermore, many of the areas men- 
tioned above also contained leu-ENK immunoreactive fibers 
and terminals (Figs. 2-7, 13, 14). 
Similarly, other investigators, who have mapped the end- 
orphins and enkeph~i~s, have noticed the anatomical prox- 
imity of these peptides to the ascending NE fibers (cf. [ 15 11). 
A potenti~ for an extensive contact between &END system 
of fibers and those of the locus coeruleus system was noted 
by Watson et al. 11481. Similarly, @-END neurons of the 
arcuate nucleus appear to be surrounded by terminals con- 
taining dopa~ne-~hydroxylase [151]+ Watson PI al. [i51] 
also have noted the presence of p-END-positive im- 
munoreactive fibers in close association with locus coeruleus 
neurons, as well as dopamine-~-hydroxylase-cont~ni~ fi- 
bers in the periaqueductal gray, medial forebrain bundle, 
periventricular thalamus, lateral septum, and certain hypo- 
thalamic nuclei. In addition to P-END innervation of the 
locus coeruleus, an enkephaline~i~ input to this nucleus has 
abo been demonstrated by both immunocytochemical 164, 
125, 141, 1511 and iontophoretic [l%] techniques. 
Opiate receptors have been demonstrated on neurons of 
the locus coeruleus [ 11, 12, 11 I]. Locus coeruleus neurons 
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MONOAMINE-OPIOID PEPTIDE INTE~CTION 
exhibit a depression in their spontaneous activity in response 
to iontophoretic [l l] or parenteral [67] administrations of 
morphine. The latter effect was naloxone reversible. 
Likewise, morphine can reduce the locus coeruleus inhibi- 
tory influence upon the spinal trigeminal nucleus [ 1261271 
and further can block the increase in the firing rate of mid- 
brain reticular neurons caused by nociceptive stimuli [45]. 
Interestingly, Gold et al. [40] have shown that alpha- 
noradrenergic blockade inhibits signs of opiate withdrawal. 
Opioid peptides are also capable of altering neuronal ac- 
tivity in certain areas of the brain. Microiontophoretic appli- 
cations of met-/leu-ENK or P-END were shown to cause 
depression in liring rate of cells in certain catecholamine rich 
regions such as locus coeruleus, periaqueductal gray, 
thalamus, caudate nucleus and frontal cortex [37, 101, 158, 
1611. Conversely, the opioid peptides produced an excitation 
of hippocampal cells [ 10 1,129]. 
The mesencephalic periaqueductal gray plays a primary 
role in the mediation of opiate-induced analgesia [47, 61,73, 
110, 140, 1571, as well as stimulation-produced analgesia [73, 
86, 881. Stimulation-produced analgesia is partially antago- 
nized by naloxone f4f. Akil and Liebeskind [2] were able to 
demonstrate a reciprocal relationship between NE mech- 
anisms and stimulation-produced analgesia thought to in- 
volve endogenous opioid systems (i.e., depression of NE 
activity potentiated the analgesia). Segal and Sandberg 11301 
have also been able to elicit stimulation-produced analgesia 
from sites in the locus coeruleus and substantia nigra. In 
agreement with this reciprocal relationship [2] and the recip- 
rocal innervation of locus coeruleus and arcuate nucleus 
alluded to above [ 1511, is the observation that stimulation of 
the arcuate nucleus resulted in the inhibition of locus 
coeruleus firing, which was also reversible by naloxone 
[133]. Thus, the P-END system is apparently inhibitory to 
the locus coeruleus-noradrenergic system, although it is not 
as yet clear whether NE is also inhibitory to arcuate @END 
neurons. Watson ef al. [146], have implicated the dorsal 
pe~vent~cular NE bundle as a possible major neu- 
roanatomic substrate for stimulation-produced analgesia. 
These investigators further noted that the production of 
analgesia was correlated with the proximity of the stimulat- 
ing electrode to this NE-containing bundle. Thus, it is appar- 
ent that the locus coeruleus-noradrenergic system is in- 
volved in the production of analgesia, be it stimulation- 
produced or morphine-induced. Furthermore, an interaction 
between this system and the P-END projection system in the 
region of the periaqueductal gray is a strong possibility. 
Other areas of possible interaction between an opioid 
peptide and ascending NE systems are the hypothalamic 
magnocellular nuclei. These nuclei, the supraoptic and 
paraventricular, are the sites of synthesis of vasopressin and 
oxytocin (cf. 128,301). Several investigators have demon- 
strated ENK immunoreactivity within magnocellular 
neurons of both the rat and cat [32, 48, 93, 119, 1251. ENK- 
containing neurons apparently form a separate but parallel 
system to those of the vasopressin and oxytocin [93]. More 
recently, another opioid peptide, DYN, has been localized to 
FACING PAGE 
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the supraoptic and paraventricular nuclei. DYN appears to 
be uniquely located within the arginine-vasopressin neurons 
[152,153]. 
It has long been known that the release of vasopressin is 
at least partially under central noradrenergic control. Both 
the supraoptic and paraventricular nuclei are areas of par- 
ticularly heavy NE innervation, as revealed by numerous 
fluorescence-histochemical studies 138, 51, 77, 89, 1431. 
There is evidence to suggest the existence of synaptic con- 
tacts of NE terminals upon m~nocellular neurons, demon- 
strated by ultrast~ctural [72, 134, 159, 1601, microion- 
tophoretic [S, 9, 24, 96, 971 and orgy-c~ture studies 11321. 
Furthermore, one of us (H. K.) has recently performed 
quantitative studies of NE input to supraoptic neurons. We 
have found the vasopressin-perikarya to be more heavily 
innervated by NE-varicosities than the oxytocin-perikarya, 
thus suggesting a differential control of hormone release by 
NE [66]. These results, when taken in light of the existence 
of DYN in vasopressin neurons, would suggest a possible 
site of interaction between NE and DYN. As interesting a 
possibility as this seems to be, it should be pointed out that 
further work remains to be done before one can speculate on 
possible implications of such interactions. 
~~pa~ine-Upi~id Peptide I~teract~u~s 
In addition to /3-END/U-MSH projections to noradrener- 
gic cell groups already mentioned, we have also noted 
/3-END/a-MSH immunoreactive fibers in the vicinity of 
substantia nigra as well as ventral tegmental dopaminergic 
nucleus. However, these are scattered fibers and it is not as 
yet clear whether they innervate these nuclei, or rather are a 
part of, and represent more ventrally situated p- 
END/or-MSH fibers which project to the brain stem (pons 
and medulla). In addition, many leu-ENK immunoreactive 
fibers were seen within the substantia nigra (Fig. 8) as well as 
along the nigrostriatal projections to the caudate-put~en 
(Fig. 9). Both leu-ENK and tyrosine hydroxylase im- 
munoreactivities were p~icularly heavy in the globus pal- 
lidus (Fig. 10). Other DA-containing cell groups such as the 
Al2 within the arcuate nucleus (Fig. 11) and the Al3 within 
the zona incerta also contained both leu-ENK and 
P-END/a?-MSH fibers and terminals. We have also noted the 
existence of tyrosine hydroxylase and leu-ENK im- 
munoreactivities in the external zone of the median emi- 
nence, surrounding the portal capillaries (Fig. 11). Lastly, in 
the pituitary, tyrosine hydroxylase-immunoreactive termi- 
nals were seen in the intermediate and posterior lobes, but 
not the anterior lobe (all intermediate lobe cells produce 
P-END and (w-MSH) (Fig. 12). 
The behavioral effects of the endorphins and enkephalins 
has led many investigators to suggest that at least some of 
the actions of these peptides may be mediated through do- 
paminergic systems, such as catalepsy [18], certain 
narcotic-induced functions [94] and neuroendocrine effects 
[90]. Met-ENK neuronal elements have been demonstrated 
in the corpus striatum, in an experiment showing that sep- 
FIG. 4. Periaqueductal gray: These photomicrographs represent serial parasagittal sections (A through F) through the mesencephalic 
periaqueductal gray (see Fig 1 for orientation), showing the common distribution of tyrosine hydroxylase (TH), leu-ENK (LE), 5HT, @-END 
(BE), o-MSH and dopamine-&hydroxylase (DBH) immunoreactive fibers. Note the position of two TH-containing cells (A) and their absence 
with DBH stain (F) representing dopamine neurons. Note also the fine innervation of the ependyma by 5HT fibers (C) and its lack of 
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FIG. 6. Nucleus tractus solitarius: Comparative distribution of tyrosine hydroxylase (TH), leu-ENK (LE), 5HT, and /?-END (BE) in serial 
parasagittal sections (A through D) through the nucleus tractus solitarius (see Fig. 1 for orientation). Note two TH-containing cells in panel A 
(belonging to the A2 noradrenergic cell group). Also note asterisk in the same capillary. Bar=50 pm. 
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FIG. 7. Dorsal catecholamine bundle: Tkse seriaI parasagittal sections show the common distribution of immunoretictive tYrOsiflt3 hp 
droxylase (TH), ~WENK (LE), /ibEND (BE) and &QX3 in panels A through D, in the ‘“dorsal catecholamine bundle” (see Fig. 1 for 
orientation). Similar results were obtained from the analysis of the ventral catecholamine bundle. Bar=50 bum+ 
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FIG. 8. Substantia n&a: The dopaminergic nucleus, substantia nigra (see Fig. 1 for orientation) is shown in serial parasagitttal sections A 
through C. Note tyrosine hydroxylase (TH)-containing cells (dopaminergic), that are in an area innervated by leu-ENK (LE) and 5HT fibers. 
Asterisk shows the same region (non-staining fibers). Bar=50 pm. 
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FIG. 9. Medial forebrain bundle: Comparative distributions of tyrosine hydroxylase (TH) and leu-ENK (LE) in serial parasagittal sections (A 
and B) through the medial forebrain bundle (see Fig. 1 for orientation). Note asterisk in the same capillary. Bar=50 pm. 
FIG. 10. Globus pallidus: Panels A and B represent serial parasagittal sections through the globus pallidus (see Fig. I for orientation). Note 
heavy tyrosine hydroxylase (TH) and leu-ENK (LE) immunoreactivities in this region. Bar=50 pm. 
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FIG. 11. Arcuate nucleus/median eminence: Serial parasagittal sections A, B, and C through the hypothalamic arcuate nucleus (see Fig. 1 for 
orientation), show tyrosine hydroxylase (TH) cells (dopaminergic), P-END (BE) cells and leu-ENK (LE) fibers in a similar location. Panels D 
and E are photomicrographs of the median eminence from the same sections as A and C showing TH and LE immunoreactivities in the 
external zone of the median eminence in contact with the portal capillaries (arrows). Note the ventral surface of the brain (dashed lines), as 
well as the third ventricle (V). 
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FIG. 12. Pituitary: Panels A and B represent serial parasagittal sections through the pituitary (see Fig. 1 for orientation). Panels C and D are 
higher power photomicrographs of A and B, respectively. Note asterisk in the same vessel in all panels. Tyrosine hydroxylase (TH) is seen to 
innervate the neural (NL) and intermediate (IL) lobes, but not the anterior lobe (AL). All IL cells and the AL corticotrophs (arrows) are 
immunoreactive for P-END (BE). The inset in Panel A shows the tine TH innervation of the NL (X is in the same vessel in Panel A and inset). 
Bar (panels A and B)= 100 pm. Bar (panels C, D, and inset)=50 pm. 
aration of striatum from substantia nigra by hemisections 
does not alter the striatal met-ENK levels, but that kainic 
acid induced lesions of the striatum does result in a marked 
depletion of caudate met-ENK levels [52]. It has also been 
suggested that at least some, but probably not all ENK- 
binding sites within the striatum are located on presynaptic 
DA terminals, since substantia nigra lesions in rats reduced 
the numbers of 3H-leu-ENK binding sites in the corpus 
striatum [115]. The latter study, however, did not separate 
the caudate-putamen from the globus pallidus, site of the 
highest ENK levels in the brain. Soon thereafter, a 
striatopallidal leu-ENK pathway was shown to exist in the 
rat by Cue110 and Paxions [25] in lesion studies that sepa- 
rated the caudate-putamen from the globus pallidus. 
Immunocytochemical studies have shown both ENK- 
perikarya [48] and tyrosine hydroxylase axon terminals [ 1141 
in the rat neostriatum. In a recent ultrastructural study. 
Pickel et al. [113] have demonstrated that the majority of 
tyrosine hydroxylase-labeled (i.e., DA) axon terminals 
within the rat neostriatum lack synaptic specializations. 
They did, however, observe a few axo-dendritic (but no 
axo-axonic) synapses, arguing that DA axons could exert 
some effect on the ENK neurons via such axo-dendritic 
junctions. Therefore, it seems likely that DA might exert a 
modulatory influence on striatal ENK neurons. 
Enkephalins are also present in the substantia nigra as 
revealed by both radioimmunoassay [53] and im- 
munocytochemistry [32. 125, 1411. Likewise, opiate recep- 
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FIG. 13. Raphe dorsalis: This large serotonergic nucleus (see Fig. I for orientation) is depicted in serial parasagittai sections (A through D). 
Tyrosine hydroxylase (TH), Ieu-ENK (LE), and o-MSH (also representing P-END) fibers are seen in proximity to 5HT neurons (panel C) of 
this nucleus. Note asterisk in the same capillary through these sections. Bar=50 urn. 
tors have been shown to exist in substantia nigra by au- 
toradiographic [ 1121 and lesion studies [82,116]. Further- 
more, evidence in support of a direct interaction between 
ENK and DA neurons has been provided by a combined 
fluorescence-immunocytochemical study showing ENK 
terminals and fibers in close relation to the DA neurons of 
the substantia nigra and ventral tegmental area [65]. 
Parenteral administration of morphine resulted in an in- 
crease in the spontaneous firing rate of substantia nigra 
neurons [58, 70, 71, 1021, but induced the suppression of 
neurons in the caudate nucleus [70,71]. The latter inves- 
tigators noted that morphine might be stimulatory to sub- 
stantia nigra-DA neurons which in turn innervate the caudate 
nucleus. In support of these experiments, an increase in 
DA-fluorescence intensity was demonstrated in the rat and 
mouse substantia nigra after morphine administration [46]. 
Thus narcotic analgesics (i.e., morphine and perhaps other 
opioid peptides) may exert an inhibitory effect at DA termi- 
nation areas which would result in sedation and catalepsy 
[57], and an excitatory influence on the DA neuronal peri- 
karya which might be due in turn to a presynaptic inhibition 
of an inhibitory neuronal influence upon those same DA per- 
ikarya [29]. 
It is becoming increasingly clear that P-END and the 
enkephalins may play a neurotransmitter or neuromodula- 
tory role in conjunction with the catecholamines in many 
brain areas (cf. [57]). P-END injected intracerebroventricu- 
larly or in the region of the periaqueductal gray of rats was 
shown to induce analgesia as well as akinesia [18,44,62,83], 
effects that were both reversed by the administration of 
L-DOPA or apomorphine [59,98]. Enkephalins may play a 
regulatory role upon the DA neurons of the substantia nigra 
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FIG. 14. Raphe magnus: The serotonergic nucleus raphe magnus (see Fig. 1 for orientation) is seen in these serial sections (A through D) to be 
innervated with leu-ENK (LE), p-END (BE), and (Y-MSH fibers. Note the 5HT neurons in panel B. Bar=50 pm. 
and the ventral tegmental area, since motor activity was en- 
hanced following the injection of opiates into these areas 
[21,109]. Furthermore, both P-END and met-ENK seem to 
influence the tuberoinfundibular DA system, since they were 
stimulatory to growth hormone and prolactin secretion [31, 
33, 42, 76, 1181. 
Serotonin (SHT)-Opioid Peptide Interactions 
In the case of 5HT, we have also noted many central 
nervous system loci of possible interaction of this 
monoamine with the opioid peptides. We have already men- 
tioned the brain stem projections of the P-END/o-MSH 
neuronal system, particularly those to noradrenergic and 
serotonergic raphe nuclei. We have noted /%END/ol-MSH 
fibers and terminals within the nucleus raphe dorsalis 
situated in and adjacent to periaqueductal gray (Fig. 13). 
Many leu-ENK immunoreactive fibers were also seen in the 
raphe dorsalis (Fig. 13). Of the other serotonergic nuclei 
examined that are innervated by both /I-END/a-MSH as well 
as leu-ENK fibers and terminals, we should also mention the 
nucleus raphe magnus (Fig. 14), raphe medianus (nucleus 
centralis superior), and raphe pontis. Of the several 
serotonergic pathways examined, one of the most striking in 
terms of a possible interaction with an opioid peptide, is the 
serotonergic projection to the dorsal horn of the spinal cord. 
Serial section examination revealed the existence of dense 
leu-ENK immunoreactivity occupying the same position in 
the dorsal horn as the SHT terminals (Fig. 15). 
It seems likely that a 5HT stimulatory mechanism might 
be involved in the release of pituitary ACTH and P-END. 
perhaps via corticotropin releasing factor. In support of this 
notion is the evidence that various stressful stimuli that can 
enhance brain 5HT turnover [ 100,137] can also increase the 
release of ACTH and /?-END [99,121]. Furthermore, direct 
evidence was provided by Sapun et al. [ 1241 for a serotoner- 
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FIG. IS. Dorsal horn of spinal cord: The serotonergic (5HT) projection to the dorsal horn (see Fig. 1 for orientation) is shown in panel B (low 
power, dark field). The adjacent section (A) demonstrates the leu-ENK (LE) fibers occupying an identical position to that of SHT. Panels C 
and D show high power, bright field photomicrographs of A and B, respectively. Arrows point to the dorsal surface of the spinal cord. Light 
bar= 100 pm. Dark bar=50 pm. 
gic stimulatory influence over the basal, and in part, the 
stress-induced release of pituitary P-END in the rat. 
Serotonergic systems may also play an important role in 
brain mechanisms of pain and analgesia [91]. Experimental 
manipulations, pharmacological or otherwise, that elevate 
brain 5HT levels, also produce analgesia in both animals and 
man [54,63, 85,92, 120, 122, 1231, while those manipulations 
which reduce SHT levels induce hyperalgesia reversible by 
5HT precursors [34,85]. 
It has been shown that the electrical stimulation of some 
brain regions such as the mesencephalic periaqueductal gray 
in the vicinity of the nucleus raphe dorsalis results in the 
production of analgesia (cf. [87]). In the rat, pretreatment 
with p-chlorophenylalanine (a 5HT synthesis inhibitor) ap- 
pears to diminish the tail-flick latency normally caused by 
periaqueductal gray stimulation [3]. Furthermore, a reversal 
of this latter effect (of p-chlorophenylalanine) was shown to 
occur with the administration of 5-hydroxytryptophan, in it- 
self a potentiator of electrical stimulation-produced analgesia 
[2]. Thus, the possibility exists for an involvement of a 
serotonergic neuronal system in the mechanism of 
stimulation-produced analgesia, at least in the periaqueduc- 
tal gray. Accordingly, experimental evidence points to a 
positive correlation between high levels of brain 5HT and 
increased anti-nociception following narcotic administration 
(cf. [20]). 
As was alluded to above, stimulation of periaqueductal 
gray results in an inhibition of pain transmission through the 
spinal cord, thus producing analgesia [l, 88, 1031. The nu- 
cleus raphe magnus seems to be involved in this mechanism 
of analgesia produced by the stimulation of periaqueductal 
gray [35]. The activity of raphe magnus neurons can be al- 
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tered by periaqueductal gray stimulation [I 173. Furthermore, 
cells of the lamina I and V of the spinal cord (involved in pain 
transmission) can be inhibited by the stimulation of raphe 
magnus [35]. However, it should be pointed out that this 
5HT system is only a part of a rather complex descending 
inhibitory system involved in the stimulation-produced or 
morphine-induced analgesia, including the nucleus re- 
ticularis paragigantocellularis [ 1351, and encompassing sev- 
eral neurotransmitter substances, such as acetylcholine, NE, 
substance P, and ENK [SO,lOS]. 
The nucleus raphe dorsalis is another 5HT nucleus in- 
volved in the mechanism of analgesia which can be induced 
by electrical stimulation or by opiates [lo, 87, 1041. It has 
been shown that stimulation of raphe dorsalis can potentiate 
morphine-induced analgesia by increasing forebrain 5HT 
levels [123]. On the other hand, raphe dorsalis lesions have 
the opposite effect on morphine analgesia [156]. In the cat, 
the raphe dorsalis appears to be even more effective a site 
than periaqueductal gray for stimulation-produced analgesia 
[104]. Recently, Moss et al. [95] have demonstrated ENK 
immunoreactive perikarya in the cat raphe dorsalis, thus 
arguing that the effectiveness of electrical stimulation of the 
cat raphe dorsalis might be due to the excitation of both 
ENK-containing and 5HT neurons. In the rat also, ENK- 
perikarya have been shown to exist in the raphe dorsalis 
[ 1411, but it appears that there are considerably fewer ENK 
neurons in the rat, especially along the midline [95]. Just how 
raphe dorsalis fits into the overall pain pathway system, par- 
ticularly the descending system involving raphe magnus, is 
not yet well understood. Moreover, through its projections 
to the limbic structures, raphe dorsalis may be involved in 
the affective side of pain perception. 
CONCLUSIONS 
It is now clear that there exists the possibility of an ex- 
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tensive and intimate interaction between the endogenous 
opioid peptides and the classical monoamine neurotransmit- 
ters. Although we can only talk about the possibility of such 
an interaction due to the limitations of light microscopic im- 
munocytochemistry, still there exist in many cases an unmis- 
takable anatomical proximity between these peptidergic sys- 
tems and the monoaminergic nuclei and projections. Elec- 
tron microscopic analyses utilizing both pre- and post- 
synaptic markers will no doubt provide answers to some of 
the crucial questions regarding the synaptic or otherwise 
synaptoid connectivity between such systems. 
It is becoming increasingly apparent that the opioid pep- 
tides play a neurotransmitter or neuromodulatory role in 
many brain regions. It is equally apparent that at least a part 
of this role is played in conjunction with the monoamines. 
Particularly, the profound behavioral effects of the opioid 
peptides are a good indication that some of their phar- 
macological actions must be mediated through the 
monoamines (i.e., catalepsy, analgesia, neuroendocrine ef- 
fects). 
Further combined pharmacological-morphological stud- 
ies using manipulative techniques whereby one can alter the 
pharmacology of one or the other system, could prove 
valuable in assessing the more subtle influences and interac- 
tions of the opioids upon the monoamines and vice versa. 
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